• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of biochemjBJ Latest papers and much more!
Biochem J. May 15, 2005; 388(Pt 1): 245–254.
Published online May 10, 2005. Prepublished online Jan 20, 2005. doi:  10.1042/BJ20041451
PMCID: PMC1186713

A mammalian fatty acid hydroxylase responsible for the formation of α-hydroxylated galactosylceramide in myelin


Hydroxylation is an abundant modification of the ceramides in brain, skin, intestinal tract and kidney. Hydroxylation occurs at the sphingosine base at C-4 or within the amide-linked fatty acid. In myelin, hydroxylation of ceramide is exclusively found at the α-C atom of the fatty acid moiety. α-Hydroxylated cerebrosides are the most abundant lipids in the myelin sheath. The functional role of this modification, however, is not known. On the basis of sequence similarity to a yeast C26 fatty acid hydroxylase, we have identified a murine cDNA encoding FA2H (fatty acid 2-hydroxylase). Transfection of FA2H cDNA in CHO cells (Chinese-hamster ovary cells) led to the formation of α-hydroxylated fatty acid containing hexosylceramide. An EGFP (enhanced green fluorescent protein)–FA2H fusion protein co-localized with calnexin, indicating that the enzyme resides in the endoplasmic reticulum. FA2H is expressed in brain, stomach, skin, kidney and testis, i.e. in tissues known to synthesize fatty acid α-hydroxylated sphingolipids. The time course of its expression in brain closely follows the expression of myelin-specific genes, reaching a maximum at 2–3 weeks of age. This is in agreement with the reported time course of fatty acid α-hydroxylase activity in the developing brain. In situ hybridization of brain sections showed expression of FA2H in the white matter. Our results thus strongly suggest that FA2H is the enzyme responsible for the formation of α-hydroxylated ceramide in oligodendrocytes of the mammalian brain. Its further characterization will provide insight into the functional role of α-hydroxylation modification in myelin, skin and other organs.

Keywords: ceramide, galactosylceramide, α-hydroxylase, myelin, Scs7p protein, sphingolipid
Abbreviations: CGT, UDP-galactose:ceramide galactosyltransferase; CHO cells, Chinese-hamster ovary cells; DIG, digoxigenin; EGFP, enhanced green fluorescent protein; ER, endoplasmic reticulum; EST, expressed sequence tag; FA2H, fatty acid 2-hydroxylase; GalC, galactosylceramide; HexC, monohexosylceramide; HFA, hydroxy fatty acid; HFAME, HFA methyl ester; IPC, inositolphosphoceramide; MALDI–TOF, matrix-assisted laser-desorption ionization–time-of-flight; NFA, non-HFA; ORF, open reading frame; PLP, proteolipid protein; VLCFA, very-long-chain fatty acid


Sphingolipids are important components of eukaryotic membranes. They are involved in many cellular functions such as signal transduction, cell–cell interactions and protein sorting [13]. Together with cholesterol, sphingolipids are essential for the formation of membrane microdomains or lipid rafts that originate in the Golgi apparatus [4]. The synthesis of sphingolipids starts in the ER (endoplasmic reticulum) with the condensation of palmitoyl-CoA and serine to form 3-oxosphinganine, which is then reduced to sphinganine. Sphinganine is acylated to form dihydroceramide, which is further modified by desaturation and hydroxylation of the sphingosine and fatty acid moiety [5]. The physiological role of the sphingosine and fatty acid hydroxylation is mostly unknown.

In myelin of the mammalian brain, more than 50% of the cere-brosides contain α-hydroxylated fatty acids. α-Hydroxylation is generated by an NAD(P)H- and O2-dependent mechanism in the microsomal fraction [6,7]. α-Hydroxylation of sphingolipids has been implicated in the stability of the myelin sheath by offering additional binding sites for ions or hydrogen bonds [8,9]. There is, however, no direct experimental evidence for a functional role of sphingolipid α-hydroxylation in the formation or maintenance of the myelin sheath.

HFA (hydroxy fatty acid)-sphingolipids are also abundant in the skin, kidney, stomach and intestines [1012]. In addition to α-hydroxylated sphingolipids, these tissues synthesize 4-hydroxysphinganine (phytosphingosine)-containing sphingolipids. It has been suggested that the additional hydroxy group increases the rigidity of intercellular lipid aggregates, which is important to build up an efficient water barrier of the skin [5]. Support for this hypothesis comes from recent observations in mice lacking the transcription factor Arnt [13]. In these mice, a significant decrease in 4- and α-hydroxy sphingolipids correlates with a functional breakdown of the water barrier function of the skin. Decreased 4-hydroxysphinganine levels have also been observed in psoriasis, which is characterized by deficits in the skin barrier function [14].

In Saccharomyces cerevisiae, the formation of the α-hydroxylated C26 fatty acid containing IPC (inositolphosphoceramide) requires the Scs7p protein, which belongs to the family of desaturases/hydroxylases [15,16]. Scs7p hydroxylates the fatty acid moiety, most probably on the level of dihydroceramide [16]. A BLAST search using Scs7p as the query enabled us to identify the EST (expressed sequence tag) and cDNA sequences potentially encoding mammalian α-hydroxylases. In the present study, we describe the identification and functional expression of a murine FA2H (fatty acid 2-hydroxylase) required for the formation of hydroxylated sphingolipids in myelin, kidney, skin and the intestinal tract.


Cloning of FA2H cDNA

To identify potential mammalian fatty acid α-hydroxylases, a BLAST search was performed with the S. cerevisiae C26 fatty acid IPC hydroxylase Scs7p [15] as the query. Several EST and cDNA sequences of murine and human origin as well as other species were found. The IMAGE consortium cDNA clone IMAGp998-B1814017Q (6476561; obtained from RZPD Deutsches Ressourcenzentrum für Genomforschung, Berlin, Germany) contains the putative start codon of FA2H, and sequencing revealed that the complete ORF (open reading frame) was present. However, we found a deletion of two nucleotides (nt 99 and 100 of the coding region) within the ORF, but this deletion was not present in most other cDNA and EST sequences in the database. This deletion was corrected by site-directed mutagenesis as described in [17] using mutagenic oligonucleotides FA2H-CT1 (5′-CCGCGGGGCCAGCCTCTACGACCTCACCAGC-3′) and FA2H-CT2 (5′-GCTGGTGAGGTCGTAGAGGCTGGCCCCGCGG-3′) and FA2H in pCMV-SPORT6 as template. The coding region and the 3′-non-coding sequence of FA2H were amplified by PCR using the oligonucleotides FA2H-sense (5′-GCAAGCTTAGCTCCGCTCTCCCGCCATGG-3′) and T7 (5′-TCTAATACGACTCACTATAGGG-3′). The PCR product was digested with HindIII and XbaI and subcloned into the pcDNA3.1/zeo(+) vector (Invitrogen, Karlsruhe, Germany), resulting in the plasmid pcDNA3.1/zeo/FA2H. An FA2H fusion protein with N-terminal EGFP (enhanced green fluorescent protein) was generated by digesting pcDNA3.1/zeo/FA2H with NcoI and XbaI, which deliberates the FA2H cDNA. After a fill-in reaction with the Klenow enzyme, the FA2H cDNA was subcloned into the SmaI site of the pEGFP-C1 plasmid (Clontech, Heidelberg, Germany), resulting in the plasmid pEGFP-FA2H. The identity of all constructs generated were confirmed by DNA sequencing.

Sequence analysis

FA2H sequences from mouse, human, drosophila, Caenorhabditis elegans and S. cerevisiae were aligned using DNAStar and the alignment was further edited using the BOXSHADE program (at http://ulrec3.uni.ch/software/BOX_form.html). Putative transmembrane domains were predicted using the TMHMM program ([18]; at http://www.cbs.dtu.dk/services/TMHMM/). Hydrophobicity plots were generated by the method of Kyte and Doolittle [19] with a window size of 17 amino acids (at http://bioinformatics.weizmann.ac.il/).

Northern-blot analysis

Total RNA of different murine tissues was isolated using acid phenol method as described in [20] or using TRIzol® (Invitrogen) according to the manufacturer's instructions. Total RNAs (20 μg/lane) were separated in 1 M formaldehyde/1% agarose gels and transferred on to positively charged Hybond-N+ nylon membranes (Amersham Biosciences, Freiburg, Germany). A 1.4 kb HindIII fragment of the FA2H cDNA and a 1.5 kb actin fragment (Stratagene, Heidelberg, Germany) were used as probes, which were prepared using the Megaprime DNA Labelling System and cytidine 5′-[α-32P]triphosphate (Amersham Biosciences). Hybridization was performed using standard procedures [20]. Radioactive signals were detected by autoradiography on X-ray films. Quantification was performed by phosphoimaging using a Bio-Imaging Analyzer BAS-1800II (Fuji Photo Film, Düsseldorf, Germany) and AIDA software (Raytest, Straubenhardt, Germany).


CHO (Chinese-hamster ovary)-CGT (UDP-galactose:ceramide galactosyltransferase) cells (kindly provided by B. Popko, University of Chicago) were maintained in DMEM (Dulbecco's modified Eagle's medium)/Nut Mix F12 (1:1, v/v), supplemented with 5% (v/v) fetal calf serum, 2 mM glutamine, 100 units/ml penicillin and 100 μg/ml streptomycin (all from Invitrogen). A total of 1 million CHO-CGT cells were seeded into 10 cm dishes and transfected using the appropriate plasmid (4 μg) and 24 μl of Lipofectamine™ (Invitrogen) in OptiMEM medium (Invitrogen). For this purpose, cells were washed twice with PBS, then 3.6 ml of OptiMEM medium was added, followed by 24 μl of Lipofectamine™ in 200 μl of OptiMEM and 4 μg of plasmid diluted in 200 μl of OptiMEM. Transfections were stopped after 12–16 h by changing the medium to normal growth medium containing 5% fetal calf serum. To generate stably transfected CHO-CGT cells expressing FA2H, cells were transfected with the plasmid pcDNA3.1/zeo/FA2H and stably transfected cells were selected using 400 μg/ml zeocin.


Cells were trypsinized 24 h after transfection and then seeded at an appropriate density on to glass coverslips. After another 24 h, cells were fixed in 4% (w/v) paraformaldehyde in PBS and processed for indirect immunofluorescence as follows. Cells were permeabilized with 0.3% Triton X-100 in PBS for 10 min, followed by blocking non-specific binding in 0.2% gelatin in PBS (overnight at 4 °C). Thereafter, rabbit anti-calnexin (Stressgen/Biomol, Hamburg, Germany) in 0.2% gelatin/PBS was applied for 2 h. After washing with PBS, Cy3-conjugated goat anti-rabbit Ig (Jackson Immunoresearch Laboratories, West Grove, PA, U.S.A.) was used to detect primary antibodies. Nuclei were stained with Hoechst dye H33258 (Sigma, Taufkirchen, Germany).

Western-blot analysis

Western-blot analysis was performed as described in [17]. Cells were lysed in 20 mM Tris/HCl (pH 8.0), 150 mM NaCl, 1% Triton X-100, 5 mM EDTA and 1 mM PMSF. Protein concentration was determined using the Bio-Rad DC protein assay. Samples of EGFP or EGFP–FA2H-transfected CHO-CGT cells were separated by SDS/PAGE (10% polyacrylamide) and blotted on to nitrocellulose membranes using the semi-dry blotting technique. Bound EGFP proteins were detected using anti-GFP antibody (Abcam, Cambridge, U.K.) and peroxidase-labelled anti-rabbit Ig (Dianova, Hamburg, Germany). The bound antibodies were visualized using chemiluminescence. For this purpose, membranes were incubated for 1 min in 2.7 mM H2O2, 1.25 mM 3-aminophthalhydrazide, 0.2 mM p-coumaric acid and 100 mM Tris/HCl (pH 8.5) and exposed to X-ray films.

Lipid extraction and TLC

Lipids were isolated from transfected CHO cells as described by van Echten-Deckert [21] with minor modifications. Briefly, cells were scraped in methanol. Then, 2 vol. of chloroform was added and lipids were extracted for 2 h at 50 °C with constant stirring. The insoluble material was removed by filtration through glass wool and lipids were dried at 45 °C under a stream of nitrogen. Desalting and alkaline hydrolysis were performed as described in [21]. Lipids were dissolved in chloroform/methanol (1:1, v/v) and stored at −20 °C. Lipids were separated on silica gel 60 TLC or HPTLC silica gel plates (Merck, Darmstadt, Germany) using the solvent system chloroform/methanol/water (35:15:2, by vol.). Lipids were visualized by spraying with 0.625 M copper sulphate in 8% (v/v) phosphoric acid [22], followed by heating for 15–20 min at 150 °C. GalC (galactosylceramide) and sulphatide from bovine brain (Sigma) were used as standards.

Acid methanolysis of sphingolipids

Total alkali-stable lipids or TLC-purified GalC were subjected to acid methanolysis. Lipids were incubated in 32% HCl/methanol/water (3:29:4, by vol.) at 78 °C for 16–18 h [15,23]. Thereafter, fatty acid methyl esters were isolated by extracting twice with n-hexane. The hexane extracts were combined, dried under nitrogen, dissolved in n-hexane and separated by TLC using light petroleum (boiling range 40–60 °C)/diethyl ether (17:3, v/v) as the solvent system. Fatty acid methyl esters were visualized as described above. Acid methanolysis products of GalC from bovine brain containing NFA-GalC (where NFA stands for non-HFA) and HFA-GalC (Sigma) and [stearoyl-2H35]N-stearoylpsychosine (cerebroside with a C182H35 fatty acid side chain) ‘N-stearoyl-d35-psychosine’; Matreya, Pleasant Gap, PA, U.S.A.) served as reference substances.

MALDI–TOF-MS (matrix-assisted laser-desorption ionization–time-of-flight MS)

Regions containing the lipid of interest were cut out from TLC plates and extracted with chloroform/methanol (1:1, v/v), dried under nitrogen and dissolved in chloroform/methanol (1:1, v/v). Then, 1 μl of the sample was mixed with 1 μl of 2,5-dihydroxybenzoic acid (10 mg/ml in 70%, v/v, acetonitrile); 1 μl of the mixture was loaded into a well of a 100-well sample plate. Mass spectra were recorded with a Voyager-DE STR mass spectrometer (PE Biosystems, Warrington, Cheshire, U.K.) in positive-ion mode (instrument settings were 25000 V accelerating voltage and 75% grid voltage). [stearoyl-2H35]N-stearoylpsychosine served as the reference substance.

In situ hybridization

Antisense and sense DIG-11-UTP-labelled RNA probes (where DIG stands for digoxigenin) of the FA2H and PLP (proteolipid protein) cDNAs were synthesized using SP6, T3 or T7 RNA polymerase (Roche Diagnostics, Mannheim, Germany) according to the manufacturer's instructions. Mice (CBA×C57BL/6 genetic background) were perfused through the left cardiac ventricle with 4% paraformaldehyde in PBS. Brains were removed and post-fixed in 4% paraformaldehyde in PBS. Brains were dehydrated, paraffin-embedded and cut at a thickness of 8 μm using a microtome (Leica HM 355 S; Leica, Lasertechnik, Heidelberg, Germany). Hybridizations were performed as described by Baader et al. [24]. Briefly, after deparaffination, sections were post-fixed in 4% paraformaldehyde in PBS. Endogenous peroxidases were inhibited by incubation with 1% H2O2/PBS for 15 min. Thereafter, sections were treated with proteinase K (10 μg/ml; 4 min) and permeabilized with 0.25% Triton X-100 (4 min). Specimens were then incubated with 0.2 M HCl (8 min), followed by 0.1 M triethanolamine/2.5 μl/ml acetic anhydride (10 min). The sections were washed once for 10 min with 2×SSC (0.15 M NaCl/0.015 M sodium citrate) at 50 °C and hybridized to DIG probes overnight at 70 °C in 50% (v/v) formamide, 1% Denhardt's solution, 0.2% SDS, 0.25 mg/ml salmon sperm DNA, 0.25 mg/ml yeast tRNA and 10% (w/v) hybridization salt (3 M NaCl, 0.1 M Pipes and 0.1 M EDTA). Sections were washed with 2×SSC at 60 °C, for 20 min with 50% formamide/1×SSC at 60 °C and for 45 min with 0.1×SSC at 70 °C. DIG probes were detected by incubation with alkaline phosphatase-conjugated anti-DIG Fab fragment (Roche Diagnostics). Bound antibodies were visualized using Nitro Blue Tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate (Merck) in 100 mM Tris/HCl (pH 9.5), 100 mM NaCl and 50 mM MgCl2.


A BLAST search using the Scs7p of S. cerevisiae [15] as the query resulted in the identification of several mammalian cDNA and EST sequences having significant similarity to the yeast enzyme. A cDNA clone harbouring the complete ORF was generated as described in the Experimental section. The gene was named FA2H (GenBank® accession no. AY660882). The murine gene is composed of seven exons spanning approx. 50 kb on chromosome 8 (according to the NCBI map viewer at http://www.ncbi.nlm.nih.gov/mapview/). The ORF of 1119 nt potentially encodes a protein of 372 amino acids with a calculated molecular mass of 43 kDa (Figure 1A). Comparison of different murine EST sequences in the databases revealed that FVB/N and C57BL/6J mice differ at three nucleotide positions [C308T, T1044G and T1061C], leading to three amino acid exchanges (T103I, F348L and L354P). Interestingly, two of them (F348L and L354P) affect conserved motifs at the C-terminus. The cDNA analysed in the present study was derived from FVB/N mice.

Figure 1
Sequence and structure prediction of murine FA2H

The encoded protein contains an N-terminal cytochrome b5 domain and four conserved histidine-containing HX(2–3)(XH)H motifs (h1–h4; Figures 1A and and1C).1C). The histidine motifs are characteristic of the family of membrane-bound lipid desaturases/hydroxylases [25,26]. These motifs probably form oxo-di-iron centres, which transfer electrons from the cytochrome b5 domain to the substrate [27]. Hydrophobicity plots (Figure 1B) indicated that the protein contains several hydrophobic regions, and the TMHMM algorithm [17] predicted four transmembrane regions (Figure 1C). Interestingly, one of the histidine motifs (h3) is within the predicted transmembrane domain TM4 of the murine, human and Drosophila protein. For the C. elegans and S. cerevisiae sequences, however, this motif lies in the cytosolic part close to the membrane region.

To examine whether FA2H encodes a functional FA2H, we used CHO-CGT cells, which are stably transfected with CGT [28]. CHO cells do not express α-hydroxylase activity [29]. We decided to use CHO-CGT instead of wild-type CHO cells since CGT has a high affinity for HFA-ceramide [29] and GalC is not converted into more complex glycolipids. The FA2H cDNA ORF was subcloned into the expression vector pcDNA3.1/zeo and transfected transiently and stably into CHO-CGT cells. Either cells transfected with pEGFP-C1 plasmid or mock-transfected cells served as the controls. After 48 h, lipids were extracted from transfected cells, subjected to alkaline hydrolysis to remove phospholipids and analysed by TLC as shown in Figure 2(A). Compared with control cells (EGFP- or mock-transfected), there was a clear increase in HexC (monohexosylceramide) species co-migrating with the HFA-GalC standard in FA2H-transfected cells, suggesting the formation of HFA-GalC.

Figure 2
Sphingolipid and fatty acid analysis of FA2H-transfected CHO cells

To verify the synthesis of hydroxylated fatty acids, the sphingolipids were subjected to acid hydrolysis and the generated fatty acid methyl esters were separated by TLC (Figure 2B). Whereas HFAMEs (HFA methyl esters) were hardly detectable in mock-transfected cells or in cells transiently transfected with the pEGFP-C1 vector, HFAME could easily be detected in FA2H-transfected cells. These results strongly suggest that FA2H-expressing CHO-CGT cells attained the ability to synthesize HFA-containing cerebrosides.

To confirm these results by an independent method and to evaluate the structure of the lipids in more detail, the sphingolipids co-migrating with GalC were isolated from the TLC plate, re-extracted with chloroform/methanol (1:1, v/v) and analysed by MALDI–TOF-MS (Figure 3). In mock- (Figure 3A) or EGFP-transfected (results not shown) cells, ions with m/z values of 722, 806 and 834 for [M+Na]+ could be detected. These mass peaks correspond to non-hydroxylated HexC species containing sphingosine with C16, C22 and C24 fatty acids respectively. In FA2H-transfected cells, additional ion peaks were observed at m/z 738, 822 and 850, indicative of hydroxylation (+16 Da; Figure 3B).

Figure 3
MALDI–TOF-MS of HexCs from FA2H-transfected CHO cells

α-Hydroxylase activity has been observed in the microsomal fraction of rat brains [7]. Therefore, and because of the synthesis of ceramide and HFA-GalC in the ER [31], it was reasonable to assume that the FA2H enzyme resides in the ER. In concordance with this, the FA2H C-terminus contains a putative ER retention signal (-HXKXX; see Figures 1A and and1C).1C). To determine the subcellular localization of the FA2H protein, we generated the expression plasmid pEGFP-FA2H, which codes for the fusion protein of FA2H with an N-terminal EGFP. CHO-CGT cells were transiently transfected with pEGFP-FA2H (Figures 4A, A,4C4C and and4E)4E) or the empty vector pEGFP-C1 (Figures 4B, B,4D4D and and4F)4F) and stained with an antibody directed against the ER marker calnexin. A high degree of co-localization of the EGFP–FA2H fusion protein with calnexin was evident (Figures 4A and and4C).4C). To confirm that the EGFP–FA2H was active, sphingolipids were extracted from EGFP–FA2H and control EGFP-transfected cells and analysed by MALDI–TOF-MS as described above. The mass spectra obtained clearly demonstrated the presence of hydroxylated HexC in EGFP–FA2H-transfected cells (Figure 3C), but not in EGFP control cells (results not shown), indicating that the fusion protein was active. Western-blot analysis of total cell lysates from transiently EGFP–FA2H-transfected cells using an anti-GFP antibody led to the detection of an approx. 70 kDa protein, which is in good agreement with the calculated mass of 71.8 kDa for the fusion protein (Figure 4G).

Figure 4
Subcellular localization of EGFP–FA2H fusion protein

Northern-blot analysis of total RNA from diverse adult mouse tissues indicated that FA2H is highly expressed in brain, skin, stomach, testis and kidney (Figure 5A). This expression pattern is in agreement with the presence of α-hydroxylated sphingolipids in these tissues [1012,32]. A very weak signal could be detected in RNA from the small intestine; however, it was too faint to be displayed in Figure 5(A). The size of the mRNA was calculated to be 2.6 kb. In brain, FA2H expression strongly increased between 1 and 2 weeks of age (Figure 5B). Expression reached the maximal level between 2 and 3 weeks of age and slightly decreased in older animals (Figures 5B and and5C).5C). This profile closely resembles that of myelin-specific genes, such as CGT, myelin basic protein or PLP [30,33,34]. Furthermore, the time course of FA2H mRNA expression in the developing mouse brain is similar to that of α-hydroxylase activity reported by Murad and Kishimoto [35], suggesting that α-hydroxylation is mainly regulated at the transcriptional level.

Figure 5
Tissue distribution of FA2H mRNA expression

In situ hybridization of 3-week-old murine brain using a DIG-labelled FA2H antisense RNA probe detected an expression of FA2H in the white matter (Figure 6). Figure 6 shows the hybridization pattern in the cerebellum (Figures 6A and and6D)6D) and forebrain (Figures 6G and and6L).6L). No hybridization signals were obtained with the sense probe (Figures 6B, B,6E,6E, E,6J6J and and6M).6M). Hybridization of adjacent sections with an antisense PLP probe (Figures 6C, C,6F,6F, F,6H6H and and6N),6N), which is a specific marker for differentiated oligodendrocytes [36], gives a very similar hybridization pattern, confirming that FA2H expression is mainly restricted to oligodendrocytes. Taken together, the above results strongly suggest that FA2H is the hydroxylase responsible for the synthesis of α-hydroxylated GalC in myelinating oligodendrocytes.

Figure 6
In situ hybridization of 3-week-old mouse brains for FA2H mRNA


We have identified murine and human cDNA sequences potentially encoding a fatty acid α-hydroxylase. The protein belongs to the family of membrane-bound lipid desaturases/hydroxylases and the following observations strongly suggest that FA2H is the hydroxylase responsible for the formation of α-hydroxylated cerebrosides and other sphingolipids. First, CHO-CGT cells, which normally do not have hydroxylated HexC [29], synthesize hydroxylated HexC after transfection with an FA2H cDNA. Secondly, FA2H contains four histidine motifs, which is characteristic of the enzyme family of lipid desaturases/hydroxylases [25,26]. Thirdly, FA2H is expressed in those tissues that synthesize α-hydroxylated sphingolipids, and the time course of FA2H expression in brain is similar to that of α-hydroxylase activity reported by Murad and Kishimoto [35]. Since FA2H expression was very low in the small intestine, we cannot rule out that a second enzyme exists that might be involved in α-hydroxylation in the intestinal tract. At least a recent database search did not indicate the presence of a second enzyme with significant sequence similarity to FA2H in the human or mouse genome (M. Eckhardt, unpublished work).

α-Hydroxylase activity in brain microsomes is NAD(P)H- and O2-dependent [6,7]. Thus probably the N-terminal cytochrome b5 domain is reduced by NADPH:cytochrome b5 reductase and then transfers electrons to the oxo-di-iron centres formed by the histidine motifs HX2-3(XH)H (h1–h4; see Figures 1A and and1C).1C). These motifs are found in all enzymes that desaturate or hydroxylate lipids in an NAD(P)H- and O2-dependent manner [26,27]. For the rat stearoyl-CoA Δ9 desaturase, all histidine residues of the histidine motifs are essential for enzymic activity [37]. Interestingly, most enzymes exhibiting desaturase activity contain only three histidine motifs [26], whereas four histidine motifs are present in the yeast and mammalian sphinganine/dihydroceramide C-4 hydroxylases [16,38] and yeast α-hydroxylase [15,39]. This suggests that the additional histidine motif might be important for the hydroxylase activity. Histidine motifs h1 and h3 are close to or (h3) maybe within transmembrane regions, and thus are ideal candidates for the active centre of the enzyme.

The immediate substrate of the α-hydroxylase has not been definitely identified. Akanuma and Kishimoto [40] suggested that neither ceramide nor the free fatty acid but an unidentified intermediate is the substrate for the α-hydroxylase in brain. In lower eukaryotes, however, there is evidence for direct hydroxylation of ceramide [16,41]. For example, yeast mutants lacking the C-4 hydroxylase Sur2p accumulate non-hydroxylated IPC, suggesting that Scs7p recognizes ceramide and prefers phytosphingosine-containing ceramide rather than non-hydroxylated ceramide as the substrate [16]. In view of the sequence similarity to the yeast enzyme, it is probable that ceramide is the substrate for the FA2H enzyme.

Yeast Scs7p and its Arabidopsis homologue are required for the synthesis of VLCFA (C26) ceramide (where VLCFA stands for very-long-chain fatty acid) [15,16,39]. Hydroxylation of C16 fatty acid-containing ceramides by Scs7p has not been reported. In contrast, transfection of FA2H into CHO cells resulted in the synthesis of hydroxylated derivatives of all HexC species. An exceptionally high proportion of VLCFA is found in the brain HFA-GalC pool [42]. One important question will be to determine whether the higher proportion of VLCFA in the α-hydroxylated ceramides is due to differences in the substrate affinity of the enzyme or different sorting of short- and long-chain fatty acid-containing ceramides within the ER membrane.

The functional role of sphingolipid hydroxylation and, in particular, α-hydroxylation is largely unknown. Several studies showed that α-hydroxylation affects the binding of sphingolipids to antibodies or toxins [43,44]. Furthermore, the calcium-dependent trans-interaction between GalC- and sulphatide-containing membranes is significantly increased when the lipids are α-hydroxylated [9,45]. Biophysical studies using artificial membranes suggest that the presence of α-hydroxy groups greatly influences the phase behaviour of membranes [9,46]. Hydroxylation of sphingolipids could increase the stability of membranes by strengthening the lateral interactions of lipids and/or proteins [8,9]. Sphingolipids are important constituents of specialized membrane microdomains or rafts, which are important for intracellular trafficking, sorting and signal transduction [4]. It is possible that α-hydroxylation influences the formation of rafts or affects lipid raft function.

HFA-sphingolipids (HFA-GalC and HFA-sulphatide) are especially abundant in myelin, specialized plasma membranes of oligodendrocytes wrapped around axons to enable fast conduction of nerve impulses by saltatory conduction [36]. We show here that FA2H is expressed in the white matter of the brain and that its expression is up-regulated during the active phase of myelination between 1 and 3 weeks of age. The time course of its expression and its in situ hybridization pattern were very similar to those of other myelin-specific genes [30,33,34] and PLP respectively. These results strongly suggest that FA2H is responsible for fatty acid α-hydroxylation in oligodendrocytes and that α-hydroxylation is mainly regulated at the transcriptional level.

Only a few indirect indications of a functional role for α-hydroxylated sphingolipids in myelin are currently available. Mice lacking the GalC-synthesizing enzyme CGT have significantly reduced HFA-sphingolipid levels [47,48]. These mice have lower nerve conduction velocities and exhibit deficits in myelin structure and a progressive demyelination [4749]. Recent observations in our laboratory showed that transgenic mice with decreased HFA-GalC content develop unstable myelin and demyelinate (S. N. Fewou, H. Büssow, V. Gieselmann and M. Eckhardt, unpublished work). The formation of a functional myelin sheath, however, does not necessarily depend on α-hydroxylated sphingolipids since myelin can be formed in urodeles (newts and salamanders) in the absence of α-hydroxylated sphingolipids [7]. Interestingly, in urodeles, there is no correlation between axonal diameter and myelin thickness, in contrast with mammals [7]. Furthermore, urodeles have a lower signal conduction velocity [7]. Whether this is only a coincidence or whether α-hydroxylated cerebrosides are required for the higher conduction velocity and to adjust myelin thickness to the axon diameter in higher vertebrates, will be answered in the future as soon as FA2H-deficient mice are available.

After submission of this paper, Alderson et al. [50] reported on the cloning of the human FA2H gene and showed that long chain fatty acids are substrates for the enzyme, although they did not test other potential substrates, e.g. ceramide.


We thank I. Ackermann for expert technical assistance and S. Schroeder for assistance with MALDI–TOF measurements. This study was supported by grants from the Deutsche Forschungsgemeinschaft to M. E. and V. G.


1. Holthuis J. C., Pomorski T., Raggers R. J., Sprong H., Van Meer G. The organizing potential of sphingolipids in intracellular membrane transport. Physiol. Rev. 2001;81:1689–1723. [PubMed]
2. Obeid L. M., Okamoto Y., Mao C. Yeast sphingolipids: metabolism and biology. Biochim. Biophys. Acta. 2002;1585:163–171. [PubMed]
3. Sperling P., Heinz E. Plant sphingolipids: structural diversity, biosynthesis, first genes and functions. Biochim. Biophys. Acta. 2003;1632:1–15. [PubMed]
4. Degroote S., Wolthoorn J., Van Meer G. The cell biology of glycosphingolipids. Semin. Cell Dev. Biol. 2004;15:375–387. [PubMed]
5. Sandhoff K., Kolter T. Biosynthesis and degradation of mammalian glycosphingolipids. Philos. Trans. R. Soc. London B Biol. Sci. 2003;358:847–861. [PMC free article] [PubMed]
6. Singh I., Kishimoto Y. Alpha hydroxylation of lignoceric acid in brain. Subcellular localization of alpha hydroxylation and the requirement for heat-stable and heat-labile factors and sphingosine. J. Biol. Chem. 1979;254:7698–7704. [PubMed]
7. Kishimoto Y. Phylogenetic development of myelin glycosphingolipids. Chem. Phys. Lipids. 1986;42:117–128. [PubMed]
8. Graf K., Baltes H., Ahrens H., Helm C. A., Husted C. A. Structure of hydroxylated galactocerebrosides from myelin at the air-water interface. Biophys. J. 2002;82:896–907. [PMC free article] [PubMed]
9. Koshy K. M., Wang J., Boggs J. M. Divalent cation-mediated interaction between cerebroside sulfate and cerebrosides: an investigation of the effect of structural variations of lipids by electrospray ionization mass spectrometry. Biophys. J. 1999;77:306–318. [PMC free article] [PubMed]
10. Karlsson K. A., Samuelsson B. E., Steen G. O. The sphingolipid composition of bovine kidney cortex, medulla and papilla. Biochim. Biophys. Acta. 1973;316:317–335. [PubMed]
11. Karlsson K., Nilsson K., Samuelsson B. E., Steen G. O. The presence of hydroxy fatty acids in sphingomyelins of bovine rennet stomach. Biochim. Biophys. Acta. 1969;176:660–663. [PubMed]
12. Madison K. C. Barrier function of the skin: ‘la raison d'etre’ of the epidermis. J. Invest. Dermatol. 2003;121:231–241. [PubMed]
13. Takagi S., Tojo H., Tomita S., Sano S., Itami S., Hara M., Inoue S., Horie K., Kondoh G., Hosokawa K., et al. Alteration of the 4-sphingenine scaffolds of ceramides in keratinocyte-specific Arnt-deficient mice affects skin barrier function. J. Clin. Invest. 2003;112:1372–1382. [PMC free article] [PubMed]
14. Motta S., Monti M., Sesana S., Caputo R., Carelli S., Ghidoni R. Ceramide composition of the psoriatic scale. Biochim. Biophys. Acta. 1993;1182:147–151. [PubMed]
15. Dunn T. M., Haak D., Monaghan E., Beeler T. J. Synthesis of monohydroxylated inositolphosphorylceramide (IPC-C) in Saccharomyces cerevisiae requires Scs7p, a protein with both a cytochrome b5-like domain and a hydroxylase/desaturase domain. Yeast. 1998;14:311–321. [PubMed]
16. Haak D., Gable K., Beeler T., Dunn T. Hydroxylation of Saccharomyces cerevisiae ceramides requires Sur2p and Scs7p. J. Biol. Chem. 1997;272:29704–29710. [PubMed]
17. Eckhardt M., Barth H., Blöcker D., Aktories K. Binding of Clostridium botulinum C2 toxin to asparagine-linked complex and hybrid carbohydrates. J. Biol. Chem. 2000;275:2328–2334. [PubMed]
18. Krogh A., Larsson B., von Heijne G., Sonnhammer E. L. L. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 2001;305:567–580. [PubMed]
19. Kyte J., Doolittle R. F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 1982;157:105–132. [PubMed]
20. Sambrook J., Fritsch E. F., Maniatis T. 2nd edn. Plainview, NY: Cold Spring Harbor Laboratory Press; 1989. Molecular Cloning: A Laboratory Manual.
21. van Echten-Deckert G. Sphingolipid extraction and analysis by thin-layer chromatography. Methods Enzymol. 2000;312:64–79. [PubMed]
22. Yao J. K., Rastetter G. M. Microanalysis of complex tissue lipids by high-performance thin-layer chromatography. Anal. Biochem. 1985;150:111–116. [PubMed]
23. Bertello L. E., Goncalvez M. F., Colli W., de Lederkremer R. M. Structural analysis of inositol phospholipids from Trypanosoma cruzi epimastigote forms. Biochem. J. 1995;310:255–261. [PMC free article] [PubMed]
24. Baader S. L., Sanlioglu S., Berrebi A. S., Parker-Thornburg J., Oberdick J. Ectopic overexpression of engrailed-2 in cerebellar Purkinje cells causes restricted cell loss and retarded external germinal layer development at lobule junctions. J. Neurosci. 1998;18:1763–1773. [PubMed]
25. Fox B. G., Shanklin J., Somerville C., Munck E. Stearoyl-acyl carrier protein delta 9 desaturase from Ricinus communis is a diiron-oxo protein. Proc. Natl. Acad. Sci. U.S.A. 1993;90:2486–2490. [PMC free article] [PubMed]
26. Ternes P., Franke S., Zähringer U., Sperling P., Heinz E. Identification and characterization of a sphingolipid delta 4-desaturase family. J. Biol. Chem. 2002;277:25512–25518. [PubMed]
27. Fox B. G., Shanklin J., Ai J., Loehr T. M., Sanders-Loehr J. Resonance Raman evidence for an Fe-O-Fe center in stearoyl-ACP desaturase. Primary sequence identity with other diiron-oxo proteins. Biochemistry. 1994;33:12776–12786. [PubMed]
28. Stahl N., Jurevics H., Moreli P., Suzuki K., Popko B. Isolation, characterization, and expression of cDNA clones that encode rat UDP-galactose:ceramide galactosyltransferase. J. Neurosci. Res. 1994;38:234–242. [PubMed]
29. van der Bijl P., Strous G. J., Lopes-Cardozo M., Thomas-Oates J., van Meer G. Synthesis of non-hydroxy-galactosylceramides and galactosyldiglycerides by hydroxy-ceramide galactosyltransferase. Biochem. J. 1996;317:589–597. [PMC free article] [PubMed]
30. Schaeren-Wiemers N., van der Bijl P., Schwab M. E. The UDP-galactose:ceramide galactosyltransferase: expression pattern in oligodendrocytes and Schwann cells during myelination and substrate preference for hydroxyceramide. J. Neurochem. 1995;65:2267–2278. [PubMed]
31. Burger K. N., van der Bijl P., van Meer G. Topology of sphingolipid galactosyltransferases in ER and Golgi: transbilayer movement of monohexosyl sphingolipids is required for higher glycosphingolipid biosynthesis. J. Cell Biol. 1986;133:15–28. [PMC free article] [PubMed]
32. Robinson B. S., Johnson D. W., Poulos A. Novel molecular species of sphingomyelin containing 2-hydroxylated polyenoic very-long-chain fatty acids in mammalian testes and spermatozoa. J. Biol. Chem. 1992;267:1746–1751. [PubMed]
33. Carson J. H., Neilson M. L., Barbarese E. Developmental regulation of myelin basic protein expression in mouse brain. Dev. Biol. 1983;96:485–492. [PubMed]
34. Sorg B. A., Smith M. M., Campagnoni A. T. Developmental expression of the myelin proteolipid protein and basic protein mRNAs in normal and dysmyelinating mutant mice. J. Neurochem. 1987;49:1146–1154. [PubMed]
35. Murad S., Kishimoto Y. Alpha hydroxylation of lignoceric acid to cerebronic acid during brain development. Diminished hydroxylase activity in myelin-deficient mouse mutants. J. Biol. Chem. 1975;250:5841–5846. [PubMed]
36. Baumann N., Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 2001;81:871–927. [PubMed]
37. Shanklin J., Whittle E., Fox B. G. Eight histidine residues are catalytically essential in a membrane-associated iron enzyme, stearoyl-CoA desaturase, and are conserved in alkane hydroxylase and xylene monooxygenase. Biochemistry. 1994;33:12787–12794. [PubMed]
38. Mizutani Y., Kihara A., Igarashi Y. Identification of the human sphingolipid C4-hydroxylase, hDES2, and its up-regulation during keratinocyte differentiation. FEBS Lett. 2004;563:93–97. [PubMed]
39. Mitchell A. G., Martin C. E. Fah1p, a Saccharomyces cerevisiae cytochrome b5 fusion protein, and its Arabidopsis thaliana homolog that lacks the cytochrome b5 domain both function in the alpha-hydroxylation of sphingolipid-associated very long chain fatty acids. J. Biol. Chem. 1997;272:28281–28288. [PubMed]
40. Akanuma H., Kishimoto Y. Synthesis of ceramides and cerebrosides containing both alpha-hydroxy and nonhydroxy fatty acids from lignoceroyl-CoA by rat brain microsomes. J. Biol. Chem. 1979;254:1050–1060. [PubMed]
41. Kaya K., Ramesha C. S., Thompson G. A. On the formation of alpha-hydroxy fatty acids. Evidence for a direct hydroxylation of nonhydroxy fatty acid-containing sphingolipids. J. Biol. Chem. 1984;259:3548–3553. [PubMed]
42. Svennerholm L., Bostrom K., Fredman P., Jungbjer B., Mansson J. E., Rynmark B. M. Membrane lipids of human peripheral nerve and spinal cord. Biochim. Biophys. Acta. 1992;1128:1–7. [PubMed]
43. Nakakuma H., Arai M., Kawaguchi T., Horikawa K., Hidaka M., Sakamoto K., Iwamori M., Nagai Y., Takatsuki K. Monoclonal antibody to galactosylceramide: discrimination of structural difference in the ceramide moiety. FEBS Lett. 1989;258:230–232. [PubMed]
44. Binnington B., Lingwood D., Nutikka A., Lingwood C. A. Effect of globotriaosyl ceramide fatty acid alpha-hydroxylation on the binding by verotoxin 1 and verotoxin 2. Neurochem. Res. 2002;27:807–813. [PubMed]
45. Boggs J. M., Menikh A., Rangaraj G. Trans interactions between galactosylceramide and cerebroside sulfate across apposed bilayers. Biophys. J. 2000;78:874–885. [PMC free article] [PubMed]
46. Shah J., Atienza J. M., Rawlings A. V., Shipley G. G. Physical properties of ceramides: effect of fatty acid hydroxylation. J. Lipid Res. 1995;36:1945–1955. [PubMed]
47. Coetzee T., Fujita N., Dupree J., Shi R., Blight A., Suzuki K., Suzuki K., Popko B. Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell (Cambridge, Mass.) 1996;86:209–219. [PubMed]
48. Bosio A., Binczek E., Stoffel W. Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc. Natl. Acad. Sci. U.S.A. 1996;93:13280–13285. [PMC free article] [PubMed]
49. Coetzee T., Dupree J. L., Popko B. Demyelination and altered expression of myelin-associated glycoprotein isoforms in the central nervous system of galactolipid-deficient mice. J. Neurosci. Res. 1998;54:613–622. [PubMed]
50. Alderson N. L., Rembiesa B. M., Walla M. D., Bielawska A., Bielawski J., Hama H. The human FA2H gene encodes a fatty acid 2-hydroxylase. J. Biol. Chem. 2004;279:48562–48568. [PubMed]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society
PubReader format: click here to try


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • Compound
    PubChem Compound links
  • EST
    Published EST sequences
  • Gene
    Gene links
  • Gene (nucleotide)
    Gene (nucleotide)
    Records in Gene identified from shared sequence links
  • GEO Profiles
    GEO Profiles
    Related GEO records
  • HomoloGene
    HomoloGene links
  • Nucleotide
    Published Nucleotide sequences
  • Pathways + GO
    Pathways + GO
    Pathways, annotations and biological systems (BioSystems) that cite the current article.
  • Protein
    Published protein sequences
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links
  • Taxonomy
    Related taxonomy entry
  • Taxonomy Tree
    Taxonomy Tree

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...